Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy

Similar documents
Shree Renuka Sugars. CMP: INR41 TP: INR50 Buy

Unitech. CMP: INR20 TP: INR30 Buy

CMP: INR121 TP: INR193 Buy

IndusInd Bank. CMP: INR345 TP: INR419 Buy

Reliance Infrastructure CMP: INR528

NTPC CMP: INR169 TP: INR191 Buy

Pidilite Industries. CMP: INR164 TP: INR186 Buy

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Jaiprakash Associates

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Godawari Power & Ispat

BGR Energy. CMP: INR266 TP: INR230 Neutral

Canara Bank. CMP: INR419 TP: INR525 Buy

BGR Energy. CMP: INR282 TP: INR253 Neutral

Idea Cellular. CMP: INR81 TP: INR Under Review

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy

IDBI Bank. CMP: INR106 TP: INR121 Neutral

BGR Energy. CMP: INR284 TP: INR296 Neutral

Sanjay Jain Pavas Pethia

Titan Industries. CMP: INR222 TP: INR220 Neutral

Cummins India. CMP: INR430 TP: INR462 Neutral

Hardick Bora

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

Canara Bank. CMP: INR464 TP: INR645 Buy

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy

Coal India CMP: INR348 TP: INR408 Buy

Hindalco. CMP: INR113 TP: INR151 Buy

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

Godrej Consumer Products

Punjab National Bank. CMP: INR716 TP: INR950 Buy

Larsen & Toubro. CMP: INR1,278 TP: INR1,380 Buy

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

Strides Arcolab. CMP: INR717 TP: INR829 Buy

Monnet Ispat. CMP: INR449 TP: INR518 Neutral

Niket Shah

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy

Sohail Halai Alpesh Mehta

CMP: INR350 TP: INR375 Downgrade to Neutral

Jinesh Gandhi Sandipan Pal

Petronet LNG. CMP: INR146 TP: INR205 Buy

Tata Power. CMP: INR111 TP: INR92 Neutral

CMP: INR415 TP: INR 471 BUY

Dabur India. CMP: INR106 TP: INR94 Neutral

Punjab National Bank. CMP: INR768 TP: INR963 Buy

Jubilant Foodworks. CMP: INR1,051 TP: INR1,054 Neutral

Idea Cellular. CMP: INR159 TP: INR200 Buy

Oberoi Realty. CMP: INR264 TP: INR315 Buy

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy

Godrej Properties. CMP: INR595 TP: INR635 Neutral

Tribhovandas Bhimji Zaveri

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

Hindustan Unilever. CMP:INR324 TP:INR302 Neutral

Stress test: Weak capital servicing ratios to drive pricing discipline

Birla Corporation. CMP: INR216 TP: INR277 Buy

Steel Authority of India

M&M Financial Services

Jinesh Gandhi Chirag Jain

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Cement. Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact

Oberoi Realty. CMP: INR269 TP: INR320 Buy

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

Dabur India. CMP: INR130 TP: INR135 Neutral

Godrej Consumer Products

Phoenix Mills. CMP: INR184 TP: INR255 Buy

Urban demand revives; Akzo gaining market share

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

Pantaloon Retail. CMP: INR177 TP: INR192 Neutral

Thermax. CMP: INR522 TP: INR414 Neutral

Siddharth Bothra

Sun Pharmaceuticals. CMP: INR554 TP: INR614 Neutral

Cross service charges at INR m/quarter

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

Maruti Suzuki. CMP:Rs1,327 TP:Rs1,625 Buy

BHEL. CMP: INR227 TP: INR233 Neutral

Godrej Properties. CMP: INR368 TP: INR420 Neutral

Coal India. CMP: INR322 TP: INR370 Buy

Jinesh Gandhi Sandipan Pal

ITC. CMP: INR201 TP: INR230 Buy

CMP: INR401 TP: INR516 Buy. * After ESOP charges; # Axon consolidated in December 2008

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Jinesh Gandhi Sandipan Pal

CPCB-2: Important long-term driver

Market share recovery, price hike, content leverage to drive growth

Godrej Consumer Products

Jinesh Gandhi Chirag Jain

Torrent Pharmaceuticals

Alpesh Mehta Sohail Halai

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy

Punjab National Bank. CMP: INR760 TP: INR964 Buy Asset quality deteriorates; asset-liability well-matched Highlights of FY12 Annual Report

Prestige Estates. CMP: INR169 TP: INR195 Buy FY13 sales booking to beat guidance by ~20%

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy

Reliance Communications

CMP: INR124 TP: INR172 Buy. Benefit of two major motorcycle launches not priced in. Improved industry outlook and recent launch success drive upgrades

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key!

Transcription:

BSE SENSEX S&P CNX 16,219 4,924 1 June 2012 6QSY12 Results Update Sector: Sugar CMP: INR26 TP: INR45 Buy Bloomberg SHRS IN Equity Shares (m) 671.0 52-Week Range (INR) 76/23 1,6,12 Rel. Perf. (%) -10/-16/-45 M.Cap. (INR b) 17.7 M.Cap. (USD b) 0.3 A - Actuals; PA - Proforma Actuals; PE - Proforma Estimates For the quarter ending March 2012 (new year end), ' revenue fell 10% YoY to IRN16.6b. EBITDA margin was stable YoY at 15.3%. Adjusted PAT was down 53% YoY to INR3.4b. Forex loss of INR1b led to reported loss of INR719m. Standalone EBITDA stood at INR1.96b, EBITDA margin expanded to 20% v/s 15.1% in 5QFY12 and net adjusted PAT was INR563m (forex loss of INR508m). Consol PBT (ex forex loss) was negative INR257m, while standalone PBT (ex forex loss) was INR679m, implying Brazil operation PBT loss was INR936m. Standalone EBITDA margin expanded due to improvement in realizations in Cogen segment (EBIT of 73% v/s 50% in 2QFY12), while EBITDA margin in Brazilian operations dropped sharply to 3.1% v/s 25.6% due to negative margins at Renuka do Brasil on account of lower productivity during off-season and higher fixed costs (lower cane yield). The company expects refinery business to improve over next couple of quarters due to (1) favorable sugar spread, (2) lower raw sugar price (makes sourcing from Brazil viable), and (3) improvement in utilization. Ongoing and planned cane plantations coupled with better weather outlook would likely to revive productivity at Brazilian operations over 2HFY13. FY13 crushing target is 9.5mt. Net debt increased to ~INR100b due to the increase in working capital debt in Indian operations, net DER stood at concerning level of 4.6x. Key triggers for the stock's re-rating are: (1) turnaround in volumes and cane yield in Brazil, (2) upswing in global sugar prices, and (3) reduction in debt. The stock trades at 3.8x FY13E EPS of INR7, and EV/EBITDA of 4.6x FY13E. We continue to value SHRS at 6x EV/ EBITDA, with a lower target price of INR45 (10% cut, on account of higher debt). Sandipan Pal (Sandipan.Pal@MotilalOswal.com); +91 22 3982 5436

Geographic composition Sales mix: Domestic 65% (43% in 5Q) and Brazil 35% (57% in 5Q). EBITDA mix: Domestic 94% (31% in 5Q) and Brazil 6% (69% in 5Q). Crushing: Total crushing volume up by 3%/4% QoQ/YoY to 3.1mt. Domestic peak season (coupled with off-season in Brazil) accounted for almost entire crushing/ production volume. Geographical Sales Mix (INR m) India Brazil 6QFY12 2QFY12 % Chg. 5QFY12 % Chg. 6QFY12 2QFY12 % Chg. 5QFY12 % Chg. (YoY) (QoQ) (YoY) (QoQ) Net Sales 9,804 12,489-21 6,975 40.6 5,356 5,556-4 9,086-41.1 EBITDA 1,965 1,351 45 1,058 85.7 125 2,098-94 2,320-94.6 EBITDA (%) 20 11 85 15 32.1 2 38-94 26-90.9 Foreign exchange (508) 342 (240) 3,952 PAT 55 292-81 291-81.1 (1,048) 130-906 2,993-135.0 Sales proportion (%) 65 69 43 35 31 57 EBITDA proportion (%) 94 39 31 6 61 69 Crushing mix (mt) Production mix (mt) Key operating metrics Domestic Business 1QSY11 2QSY11 3QSY11 4QSY11 5QFY12 6QFY12 YoY (%) Sugarcane Crushed (t) 1,674,090 2,803,472 748,680-1,759,303 3,038,845 8 Raw Sugar Processed (t) 120,813 69,770 70,750 117,828 81,685 169,018 142 Recovery (%) 10.4 12.2 12.1-11.0 12.4 1 Sugar From Cane (t) 167,301 342,958 90,758-192,724 378,158 10 - Raw Sugar (t) - White Sugar (t) 167,301 342,958 90,758-192,724 378,158 10 Refined Sugar (t) 114,039 67,080 66,980 110,921 78,417 164,310 145 Total Sugar Produced 281,340 410,038 157,738 110,921 271,141 542,468 32 Ethanol Production (KL) 17,594 42,952 40,852 9,019 25,094 49,312 15 Realization (INR/Ltr) 28 28 27 29 29 28 2 Co-generation Exports (mm units) 108 150 81 19 79 154 3 Realizations (INR/Unit) 3.8 5.4 6.4 3.5 4.5 4.8 (12) 1 June 2012 2

Key operating metrics Brazil Business 1QSY11 2QSY11 3QSY11 4QSY11 5QFY12 6QFY12 YoY (%) Sugarcane Crushed (t) 2,779,552 170,662 3,359,838 3,600,790 1,229,294 42,535 (75) Raw Sugar Processed (t) - - - - Recovery (%) 129.7 106 117 138 134 134 26 Sugar From Cane (t) 165,996 6,790 167,124 289,075 93,201 2,830 (58) - Raw Sugar (t) 157,576 6,790 113,336 289,075 93,076 2,830 - White Sugar (t) 8,420-53,788-125 - Refined Sugar (t) - - - - - Total Sugar Produced 165,996 6,790 167,124 289,075 93,201 2,830 (44) Ethanol Production (KL) 111,817 8,548 129,519 118,210 39,561 1,018 (88) Realization (INR/Ltr) 32 38.1 47 37 35 34.4 (10) Co-generation Exports (mm units) 120 40.0 95 123 187 49 23 Realizations (INR/Unit) 4.6 4.5 4.1 4.1 4.3 2.6 (41) India operations: Peak crushing season Sales up 41% QoQ (-22% YoY) to INR9.8b. YoY declined is owing to 36%YoY decline in sugar sales. Sugar sales dropped due to 19%/6%YoY drop in volume/realizations, although production is up by 32%. EBITDA margin expanded strongly to 20% from 10.9% in 2QFY12 due to improvement in realizations in Cogen segment (EBIT of 73% v/s 50% in 2QFY12). Crushing improved 8% YoY to 3mt; Recovery rates improved to 12.4% v/s 11% in 5QFY11. Sugar segment: Volume up QoQ, while realizations declined Production up 32% YoY to 0.54mt - refinery volume witnessed strong growth to 0.16mt due to favorable white-raw spread (capacity of 9,000t/day). With domestic sugar stocks finishing, the company is expected to source Brazilian raw sugar for refinery purpose post June-12 (lower raw sugar price and favorable spread makes it viable) New Crushing season refinery volume stood at 0.24mt as against estimates of 0.58mt till Sep-12. Despite improvement in production volume sales were down by 19%YoY to 0.19mt. Blended realizations down 5% QoQ (6% YoY) to INR27/kg. Ethanol segment: Volumes/Realizations declined 6%YoY; EBIT margin rose to 35% from 26% in 2QSY11. Ethanol blending program continues to drive demand. Sales to oil marketing companies (OMCs) stood at 30ml v/s 6ml 5QFY12. The company has received orders for the supply of 75ml to OMCs during the year Oct-11 to Sep- 12. Average ethanol realization in 6QFY12 was INR28.2/l v/s. INR28.9/l 5QSY11. The company believes the proposal of linking ethanol price with domestic petrol prices is likely to boost realizations, although no decision has been taken yet. The management also mentioned that given the current shortage of ethanol, world market could be supportive of ethanol exports in the nearterm (export realizations of INR38/l). Co-generation: Volumes/realizations up 3% YoY; EBIT margin rose to 73% v/s 50% 2QSY11. Realization improved QoQ to INR4.8/unit. Operating margin improved due to lower cost of fuel, primarily as the company used its own bagasse. 1 June 2012 3

Standalone Segmental Performance (INR m) Y/E September FY12 QoQ YoY 1Q 2Q 3Q 4Q 5Q 6Q (%) (%) Sugar 8,368 6,981 8,493 5,994 4,517 4,498 (0) (36) Cogeneration 725 1,363 877 407 692 1,753 153 29 Trading 2,085 4,274 1,931 4,166 1,984 4,031 103 (6) Ethanol 378 910 895 1,087 452 870 92 (4) Others 6 17 30 10 7 10 43 (41) Total 11,562 13,545 12,226 11,664 7,652 11,162 46 (18) Less: Intersegment Rev. 548 1,056 154 391 682 1,359 99 29 Total Revenue 11,014 12,489 12,072 11,273 6,970 9,803 41 (22) Segmental PBIT Sugar 758 341 459 169 442 241 (45) (29) Cogeneration 58 679 382 (15) 314 1,286 310 89 Trading 51 181 88 65 67 13 (81) (93) Ethanol 64 237 395 186 129 308 139 30 Others (1) (5) 27 5 (1) 6 (700) (220) Total 930 1,433 1,351 410 951 1,854 95 29 Segmental PBIT Margin (%) Sugar 9.1 4.9 5.4 2.8 9.8 5.4 Cogeneration 8.0 49.8 43.6 (3.7) 45.4 73.4 Trading 2.4 4.2 4.6 1.6 3.4 0.3 Ethanol 16.9 26.0 44.1 17.1 28.5 35.4 Sugar sales declined despite higher production Average realization dropped QoQ (mt) QoQ movement of export and domestic sugar prices Ethanol volume up QoQ, realization stable 1 June 2012 4

Strong co-generation, volume/price up sharply Refinery volume (mt) up with favorable White-raw spread Raw and White sugar price trend (USD/t) White-raw spread was favorable (USD/t) Domestic sugar price has been between INR2,800-3,000/quintal Brazilian operation: Off-season muted volume Sales and EBITDA deteriorated due to lower productivity: Sales were down 40% QoQ to INR5.4b, while EBITDA margin dropped sharply to 3.1% v/s 25.6% due to negative margins at Renuka do Brasil on account of lower productivity during offseason and higher fixed costs (lower cane yield). 1 June 2012 5

Revenue Break-up (INR m) EBITDA Break-up (INR m) Planting target achieved: During 5QFY12, the company achieved its plantation target of ~25,000 ha (20,045ha at RDB and 5,136 ha at VDI). We expect productivity to improve over 2HFY13 with ongoing cane plantations (25,000ha done in FY12, and another 24,000ha planned in FY13). Sugar realizations down QoQ at 24.5c/lb: Sugar realizations stood at 24.2-24.9/lb (hedged floor price of 23c/lb) on the back of declining trend of international price. Brazilian Subsidiary Performance (INR m) Renuka do Brasil Vale do Ivai Cons.Brazil 6QFY12 2QFY12 Chg. (YoY) 6QFY12 2QFY12 Chg. (YoY) Operations Net Revenue 4,600 5,257-12.5 836 271 208 5,436 EBITDA -101 1,966-105.1 270 162 67 169 EBITDA (%) -2.2 37.4 32.3 59.8 3.1 PAT -1,056 51-2171 142 103 38-914 Valuation and view: Progress in co-gen divestment and turnaround in Brazil operations would be key catalysts SHRS is the only sugar/ethanol producer in the world with almost year-long cane crushing activity as it has operations in Brazil and India, which have complementary cane crushing seasons. This allows it to: (1) manage inventory, (2) benefit from price arbitrage between sugar/ethanol, raw/white sugar, (3) play price arbitrage between India's regulated sugar industry and liquid global markets, and (4) leverage synergies, minimize risks and offer steady returns despite cyclical nature of the industry. Adverse weather that impacted production volume and margins at its Brazilian operations, coupled with lower production expectation in refinery business, have taken a huge toll on the stock performance post 4QFY12. Its high leverage level also remains a major near-term overhang on the stock. However, going forward, we believe the stock could see meaningful upside with (a) progress in co-gen divestment (a trigger for de-leveraging), (b) re-plantation improving productivity/yield in Brazilian subsidiaries, (c) robust domestic outlook. Key triggers for the stock's re-rating are: (1) turnaround in volumes and cane yield in Brazil, (2) upswing in global sugar prices, and (3) reduction in debt. The stock trades at 3.8x FY13E EPS of INR7, and EV/EBITDA of 4.6x FY13E. We continue to value SHRS at 6x EV/EBITDA, with a lower target price of INR45 (10% cut, on account of higher debt). 1 June 2012 6

Financials and Valuation 1 June 2012 7

Disclosures This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered Yes Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. MOSt is not a registered broker-dealer in the United States (U.S.) and, therefore, is not subject to U.S. rules. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., Motilal Oswal has entered into a chaperoning agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo"). This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, Marco Polo and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. Motilal Oswal Securities Ltd 3rd Floor, Hoechst House, Nariman Point, Mumbai 400 021 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com